Nebula Research & Development LLC Tango Therapeutics, Inc. Transaction History
Nebula Research & Development LLC
- $836 Billion
- Q3 2024
A detailed history of Nebula Research & Development LLC transactions in Tango Therapeutics, Inc. stock. As of the latest transaction made, Nebula Research & Development LLC holds 10,901 shares of TNGX stock, worth $38,807. This represents 0.01% of its overall portfolio holdings.
Number of Shares
10,901Holding current value
$38,807% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding TNGX
# of Institutions
122Shares Held
87.8MCall Options Held
2.6KPut Options Held
1K-
Trv Gp Iv, LLC Boston, MA16.9MShares$60 Million80.09% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA13.3MShares$47.5 Million4.45% of portfolio
-
Boxer Capital, LLC San Diego, CA8.2MShares$29.2 Million3.91% of portfolio
-
Nextech Invest Ag5.53MShares$19.7 Million6.95% of portfolio
-
Southpoint Capital Advisors LP New York, NY5.28MShares$18.8 Million1.32% of portfolio
About Tango Therapeutics, Inc.
- Ticker TNGX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 88,067,296
- Market Cap $314M
- Description
- Tango Therapeutics, Inc., a biotechnology company, discovers and develops drugs for the treatment of cancer. Its lead program is TNG908, a synthetic lethal small molecule inhibitor of protein arginine methyltransferase 5 that is being developed as a treatment for cancers with methylthioadenosine phosphorylase deletions. The company also develops...